4.7 Article

On the role of FAN1 in Fanconi anemia

期刊

BLOOD
卷 120, 期 1, 页码 86-89

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2012-04-420604

关键词

-

资金

  1. Generalitat de Catalunya [SGR0489-2009]
  2. Institut Catala de Recerca i Estudis Avancats-Academia award
  3. Spanish Ministry of Science and Innovation [CB06/07/0023, SAF2009-11936]
  4. European Regional Development Funds

向作者/读者索取更多资源

Fanconi anemia (FA) is a rare bone marrow failure disorder with defective DNA interstrand crosslink repair. Still, there are FA patients without mutations in any of the 15 genes individually underlying the disease. A candidate protein for those patients, FA nuclease 1 (FAN1), whose gene is located at chromosome 15q13.3, is recruited to stalled replication forks by binding to monoubiquitinated FANCD2 and is required for interstrand crosslink repair, suggesting that mutation of FAN1 may cause FA. Here we studied clinical, cellular, and genetic features in 4 patients carrying a homozygous 15q13.3 microdeletion, including FAN1 and 6 additional genes. Biallelic deletion of the entire FAN1 gene was confirmed by failure of 3' - and 5' -PCR amplification. Western blot analysis failed to show FAN1 protein in the patients' cell lines. Chromosome fragility was normal in all 4 FAN1-deficient patients, although their cells showed mild sensitivity to mitomycin C in terms of cell survival and G(2) phase arrest, dissimilar in degree to FA cells. Clinically, there were no symptoms pointing the way to FA. Our results suggest that FAN1 has a minor role in interstrand crosslink repair compared with true FA genes and exclude FAN1 as a novel FA gene. (Blood. 2012;120(1):86-89)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, General & Internal

Utilidad clinica del estudio genetico en pacientes con miocardiopatia dilatada

Maria Luisa Pena-Pena, Juan Pablo Ochoa, Roberto Barriales-Villa, Marcos Cicerchia, Julian Palomino-Doza, Joel Salazar-Mendiguchia, Arsonval Lamounier, Juan Pablo Trujillo, Diego Garcia-Giustiniani, Xusto Fernandez, Martin Ortiz-Genga, Lorenzo Monserrat, Maria Generosa Crespo-Leiro

Summary: This study aimed to describe the genetic basis of dilated cardiomyopathy (DCM) in a cohort with a high proportion of transplanted patients. The clinical prevalence of familial disease was found to be 37%, with most genetic variants located in sarcomeric genes. The yield of genetic testing was high, reaching 69% in familial cases, providing valuable prognostic information.

MEDICINA CLINICA (2021)

Article Biochemistry & Molecular Biology

CSVS, a crowdsourcing database of the Spanish population genetic variability

Maria Pena-Chilet, Gema Roldan, Javier Perez-Florido, Francisco M. Ortuno, Rosario Carmona, Virginia Aquino, Daniel Lopez-Lopez, Carlos Loucera, Jose L. Fernandez-Rueda, Asuncion Gallego, Francisco Garcia-Garcia, Anna Gonzalez-Neira, Guillermo Pita, Rocio Nunez-Torres, Javier Santoyo-Lopez, Carmen Ayuso, Pablo Minguez, Almudena Avila-Fernandez, Marta Corton, Miguel Angel Moreno-Pelayo, Matias Morin, Alvaro Gallego-Martinez, Jose A. Lopez-Escamez, Salud Borrego, Guillermo Antinolo, Jorge Amigo, Josefa Salgado-Garrido, Sara Pasalodos-Sanchez, Beatriz Morte, Angel Carracedo, Angel Alonso, Joaquin Dopazo

Summary: The Collaborative Spanish Variability Server (CSVS) is a database containing genomes and exomes of unrelated Spanish individuals, generated through a crowdsourcing effort. It provides data support for studying disease variants and population genetic variations, with a web interface for querying and conducting pseudo-control studies for diseases.

NUCLEIC ACIDS RESEARCH (2021)

Letter Cardiac & Cardiovascular Systems

Shprintzen-Goldberg syndrome and aortic dilatation: apropos of 2 new cases

Juan Pablo Trujillo-Quintero, Elisabeth Gabau Vila, Jose Maria Larranaga Moreira, Anna Ruiz Nello, Lorenzo Monserrat, Roberto Barriales-Villa

REVISTA ESPANOLA DE CARDIOLOGIA (2021)

Article Genetics & Heredity

FANCA Gene Mutations in North African Fanconi Anemia Patients

Abir Ben Haj Ali, Olfa Messaoud, Sahar Elouej, Faten Talmoudi, Wiem Ayed, Fethi Mellouli, Monia Ouederni, Sondes Hadiji, Annachiara De Sandre-Giovannoli, Valerie Delague, Nicolas Levy, Massimo Bogliolo, Jordi Surralles, Sonia Abdelhak, Ahlem Amouri

Summary: The population in North Africa exhibits a high consanguinity rate and a potentially high proportion of founder mutations, which may contribute to the prevalence of recessive genetic disorders like Fanconi anemia. In this study, clinical, cytogenetic, and molecular characterization of FANCA in 29 North African FA patients was conducted, revealing high rates of spontaneous chromosome breakages and identifying several causal mutations. Furthermore, three founder mutations were identified in a majority of Tunisian patients, highlighting the importance of considering the mutational landscape in genetic counseling.

FRONTIERS IN GENETICS (2021)

Article Hematology

Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients

Maria Jose Ramirez, Roser Pujol, Juan Pablo Trujillo-Quintero, Jordi Minguillon, Massimo Bogliolo, Paula Rio, Susana Navarro, Jose A. Casado, Isabel Badell, Estela Carrasco, Judith Balmana, Albert Catala, Julian Sevilla, Cristina Belendez, Bienvenida Argiles, Monica Lopez, Cristina Diaz de Heredia, Gayatri Rao, Eileen Nicoletti, Jonathan D. Schwartz, Juan A. Bueren, Jordi Surralles

Summary: Fanconi anemia is a genetic disorder characterized by chromosome fragility, bone marrow failure, and predisposition to cancer. A study in Spain found that mosaic FA patients had more favorable long-term clinical outcomes, with some showing multilineage mosaicism. This reverse mosaicism was associated with older age, lower percentage of aberrant cells, and more stable hematology in these patients.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Article Genetics & Heredity

Generating New FANCA-Deficient HNSCC Cell Lines by Genomic Editing Recapitulates the Cellular Phenotypes of Fanconi Anemia

Ricardo Errazquin, Esther Sieiro, Pilar Moreno, Maria Jose Ramirez, Corina Lorz, Jorge Peral, Jessica Ortiz, Jose Antonio Casado, Francisco J. Roman-Rodriguez, Helmut Hanenberg, Paula Rio, Jordi Surralles, Carmen Segrelles, Ramon Garcia-Escudero

Summary: The study describes the generation and characterization of FANCA-mutant cell clones in head and neck squamous cell carcinoma cell lines using CRISPR/Cas9 editing. The mutant cells exhibit sensitivity to DNA interstrand crosslink agents and display phenotypes associated with Fanconi anemia.
Review Genetics & Heredity

CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative

Juan Luque, Ingrid Mendes, Beatriz Gomez, Beatriz Morte, Miguel Lopez de Heredia, Enrique Herreras, Virginia Corrochano, Juan Bueren, Pia Gallano, Rafael Artuch, Cristina Fillat, Luis A. Perez-Jurado, Lluis Montoliu, Angel Carracedo, Jose M. Millan, Susan M. Webb, Francesc Palau, Pablo Lapunzina

Summary: CIBERER, a thematic area of CIBER, focuses on rare disease research. It aims to facilitate collaboration between biomedical and clinical research groups and provide new tools for the diagnosis and therapy of low-prevalence diseases.

CLINICAL GENETICS (2022)

Article Genetics & Heredity

Fanconi-like anemia related to a FANCM mutation

J. A. Encarnacion, P. Cerezuela, I Espanol, M. R. Garcia, C. Manso, I De la Fuente, N. Garrigos, A. Viney, J. Minguillon, J. Surralles

Summary: Fanconi anemia is primarily inherited as an autosomal recessive genetic disorder, leading to a high risk of solid tumors in the head and neck or anogenital regions. Mutations in the FANCM gene may be associated with solid tumors, genetic predisposition for breast and ovarian cancer, and hematological malignancies.

EUROPEAN JOURNAL OF MEDICAL GENETICS (2022)

Article Oncology

CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival

Jordi Minguillon, Maria Jose Ramirez, Llorenc Rovirosa, Pilar Bustamante-Madrid, Cristina Camps-Fajol, Gorka Ruiz de Garibay, Hermela Shimelis, Helena Montanuy, Roser Pujol, Gonzalo Hernandez, Massimo Bogliolo, Pau Castillo, Penny Soucy, Griselda Martrat, Antonio Gomez, Daniel Cuadras, Maria J. Garcia, Javier Gayarre, Conxi Lazaro, Javier Benitez, Fergus J. Couch, Miquel Angel Pujana, Jordi Surralles

Summary: The study discovered that CDK5RAP3 is a new BRCA2-interacting protein that negatively regulates DNA repair. Overexpression of CDK5RAP3 in breast cancer is associated with poorer survival. Additionally, common genetic variations in the CDK5RAP3 locus may be associated with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

CANCERS (2022)

Article Hematology

Metformin for treatment of cytopenias in children and young adults with Fanconi anemia

Jessica A. Pollard, Elissa Furutani, Shanshan Liu, Erica Esrick, Laurie E. Cohen, Jacob Bledsoe, Chih-Wei Liu, Kun Lu, Maria Jose Ramirez de Haro, Jordi Sumalles, Maggie Malsch, Ashley Kuniholm, Ashley Galvin, Myriam Armant, Annette S. Kim, Kaitlyn Ballotti, Lisa Moreau, Yu Zhou, Daria Babushok, Farid Boulad, Clint Carroll, Helge Hartung, Amy Hont, Taizo Nakano, Tim Olson, Sei-Gyung Sze, Alexis A. Thompson, Marcin W. Wlodarski, Xuesong Gu, Towia A. Libermann, Alan D'Andrea, Markus Grompe, Edie Weller, Akiko Shimamura

Summary: This study investigated the feasibility and tolerability of metformin treatment in patients with Fanconi anemia (FA). The results showed that metformin is safe and tolerable in nondiabetic patients with FA and may provide therapeutic benefits.

BLOOD ADVANCES (2022)

Article Oncology

Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia

Ricardo Errazquin, Angustias Page, Anna Sunol, Carmen Segrelles, Estela Carrasco, Jorge Peral, Alicia Garrido-Aranda, Sonia Del Marro, Jessica Ortiz, Corina Lorz, Jordi Minguillon, Jordi Surralles, Cristina Belendez, Martina Alvarez, Judith Balmana, Ana Bravo, Angel Ramirez, Ramon Garcia-Escudero

Summary: Fanconi anemia (FA) patients often develop oral squamous cell carcinoma (OSCC), which is diagnosed within the first 3-4 decades of life and is often preceded by lesions that undergo malignant transformation. This study found that Fanca gene knockout mice frequently display premalignant lesions in the oral cavity. When these mice were crossed with mice with conditional deletion of the Trp53 gene in the oral mucosa, they spontaneously developed OSCC with high penetrance and a median latency of less than ten months. In conclusion, Fanca and Trp53 genes cooperate to suppress oral cancer in mice, and these mice constitute the first animal model of spontaneous OSCC in FA.

ORAL ONCOLOGY (2022)

Article Multidisciplinary Sciences

High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

Marta Palafox, Laia Monserrat, Meritxell Bellet, Guillermo Villacampa, Abel Gonzalez-Perez, Mafalda Oliveira, Fara Braso-Maristany, Nusaibah Ibrahimi, Srinivasaraghavan Kannan, Leonardo Mina, Maria Teresa Herrera-Abreu, Andreu Odena, Monica Sanchez-Guixe, Marta Capelan, Analia Azaro, Alejandra Bruna, Olga Rodriguez, Marta Guzman, Judit Grueso, Cristina Viaplana, Javier Hernandez, Faye Su, Kui Lin, Robert B. Clarke, Carlos Caldas, Joaquin Arribas, Stefan Michiels, Alicia Garcia-Sanz, Nicholas C. Turner, Aleix Prat, Paolo Nuciforo, Rodrigo Dienstmann, Chandra S. Verma, Nuria Lopez-Bigas, Maurizio Scaltriti, Monica Arnedos, Cristina Saura, Violeta Serra

Summary: CDK4/6 inhibitors combined with endocrine therapy show higher antitumor activity in the treatment of estrogen receptor-positive breast cancer. Overexpression of p16 is associated with reduced effectiveness of CDK4/6 inhibitors, while heterozygous RB1 loss is a biomarker of acquired resistance and poor clinical outcome. Combination of CDK4/6 inhibitor ribociclib with PI3K inhibitor alpelisib demonstrates antitumor activity regardless of specific mutations, even without endocrine therapy.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer

Andrew L. H. Webster, Mathijs A. Sanders, Krupa Patel, Ralf Dietrich, Raymond J. Noonan, Francis P. Lach, Ryan R. White, Audrey Goldfarb, Kevin Hadi, Matthew M. Edwards, Frank X. Donovan, Remco M. Hoogenboezem, Moonjung Jung, Sunandini Sridhar, Tom F. Wiley, Olivier Fedrigo, Huasong Tian, Joel Rosiene, Thomas Heineman, Jennifer A. Kennedy, Lorenzo Bean, Rasim O. Rosti, Rebecca Tryon, Ashlyn-Maree Gonzalez, Allana Rosenberg, Ji-Dung Luo, Thomas S. Carroll, Sanjana Shroff, Michael Beaumont, Eunike Velleuer, Jeff C. Rastatter, Susanne Wells, Jordi Surralles, Grover Bagby, Margaret L. MacMillan, John E. Wagner, Maria Cancio, Farid Boulad, Theresa Scognamiglio, Roger Vaughan, Kristin G. Beaumont, Amnon Koren, Marcin Imielinski, Settara C. Chandrasekharappa, Arleen D. Auerbach, Bhuvanesh Singh, David Kutler, Peter J. Campbell, Agata Smogorzewska

Summary: Fanconi anaemia (FA) is a model syndrome of genome instability caused by a deficiency in DNA interstrand crosslink repair. FA SCCs display high numbers of structural variants and may undergo epithelial-to-mesenchymal transition and enhanced keratinocyte-intrinsic inflammatory signaling, contributing to their aggressive nature.

NATURE (2022)

Article Medicine, Research & Experimental

Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia

Jose A. Casado, Antonio Valeri, Rebeca Sanchez-Dominguez, Paula Vela, Andrea Lopez, Susana Navarro, Omaira Alberquilla, Helmut Hanenberg, Roser Pujol, Jose-Carlos Segovia, Jordi Minguillon, Jordi Surralles, Cristina Diaz de Heredia, Julian Sevilla, Paula Rio, Juan A. Bueren

Summary: Fanconi anemia (FA) is the most common inherited bone marrow failure syndrome, and the pathophysiological mechanisms of FA have not been fully elucidated. This study found that hematopoietic stem and progenitor cells (HSPCs) in FA patients express stress molecules NKG2D-Ls, which interact with activating receptor NKG2D in NK or CD8(+) T cells, leading to progressive depletion of HSPCs. Blocking NKG2D-NKG2D-L interactions can improve hematopoietic function and alleviate anemia in FA patients.

JOURNAL OF CLINICAL INVESTIGATION (2022)

暂无数据